ZE4-73678-54329

3 vaccinations 9 coded responses 31 check-ins 9 free-text entries 5 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 191 / PA
Registered: 2020-12-20

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Registered in v-safe
2020-12-20
Dose 1 — Pfizer-BioNTech
2020-12-20
Health check-in — day 0, dose 1
Feeling: Fair · Headache, Muscle or body aches

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2020-12-21
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2020-12-22
Survey response — days 1–6 daily, dose 1
MedDRA: Condition aggravated, Cough, Pre-existing disease — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Mild cough/asthma exacerbation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Nausea

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-03
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-07
Dose 2 — Pfizer-BioNTech
2021-01-07
Health check-in — day 0, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-07
Report sent to call center — day 0, dose 2
Be unable to do your normal daily activities

no matching call case
2021-01-08
Survey response — days 1–6 daily, dose 2
MedDRA: Cough, Pre-existing disease — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Free text: Mild cough (history of asthma)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-09
Survey response — days 1–6 daily, dose 2
MedDRA: Chest discomfort, Cough, Pre-existing disease — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Free text: Chest tightness/mild cough (asthma history)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-09
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-01-11
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site hypersensitivity, Injection site pain — Feeling: Good

Free text: Injection site still sore/sensitive but not painful

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-14
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-21
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-28
Survey response — day 21, dose 2
MedDRA: Asthma prophylaxis, Chest discomfort, Cough, Headache, Pre-existing disease — Feeling: Fair

Free text: Headache, chest tightness and slight cough (asthma exacerbation)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-04
Survey response — day 28, dose 2
MedDRA: Chest discomfort, Cough — Feeling: Good

Free text: Intermittent cough/chest tightness (similar to asthma exacerbation)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-11
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-02-18
Survey response — day 42, dose 2
MedDRA: Asthma, Chest discomfort, Cough — Feeling: Fair · Be unable to do your normal daily activities

Free text: Moderate asthma exacerbation (chest tightness, persistent cough)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-08
Survey response — 3 months, dose 2
MedDRA: Asthma — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Asthma exacerbation (more frequent use of rescue inhaler, 6 day course of pulse steroids)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-08
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-31
Call successful
Participant prefers to complete VAERS report online
2021-07-10
Survey response — 6 months, dose 2
MedDRA: Adrenal insufficiency, Palpitations — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Adrenal insufficiency; heart palpitations

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-10
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-16
Call 1 — Left Voicemail
2021-12-10
Dose 3 — Pfizer-BioNTech
2021-12-23
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-24
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-31
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-01-07
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-14
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-22
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-03-11
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech
2	2021-01-07	Pfizer-BioNTech
3	2021-12-10	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2020-12-21	priority 2/3
2021-01-08	priority 2/3
2021-01-09	priority 2/3
2021-04-08	Successful 2021-05-31	Participant prefers to complete VAERS report online
2021-07-10	Unsuccessful

1 report(s) with no call case — see the timeline.

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-22

Systemic reaction (other): Mild cough/asthma exacerbation

Release 1 — days 1–6 daily, dose 2

2021-01-08

Systemic reaction (other): Mild cough (history of asthma)

2021-01-09

Systemic reaction (other): Chest tightness/mild cough (asthma history)

2021-01-11

Systemic reaction (other): Injection site still sore/sensitive but not painful

Release 2 — day 21, dose 2

2021-01-28

Symptoms: Headache, chest tightness and slight cough (asthma exacerbation)

Release 3 — day 28, dose 2

2021-02-04

Symptoms: Intermittent cough/chest tightness (similar to asthma exacerbation)

Release 4 — day 42, dose 2

2021-02-18

Symptoms: Moderate asthma exacerbation (chest tightness, persistent cough)

Release 7 — 3 months, dose 2

2021-04-08

Symptoms: Asthma exacerbation (more frequent use of rescue inhaler, 6 day course of pulse steroids)

Release 9 — 6 months, dose 2

2021-07-10

Symptoms: Adrenal insufficiency; heart palpitations

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adrenal insufficiency	✓	✓	✓
SD	Asthma	✓	✓	✓
SD	Asthma prophylaxis	✓	✓	✓
SD	Chest discomfort	✓	✓	✓
SD	Cough	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Palpitations	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Asthma	○	○	○
SRO	Chest discomfort	✓	✓	✓
SRO	Condition aggravated	✓	✓	✓
SRO	Cough	✓	✓	✓
SRO	Injection site discomfort	○	○	○
SRO	Injection site hypersensitivity	✓	✓	✓
SRO	Injection site pain	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release